U
|
erythromycin A9-oxime (E); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-�\-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-�]-.sc.d.sc.-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)
13127-18-9
|
U
SAS Classification Model: ToxTree
Australia GHS
|
|
U
No structural information available
|
72480-33-2
|
U
Canadian Domestic Substances List
|
U
|
7786-30-3
|
U
Canadian Domestic Substances List
Canadian Workplace Hazardous Materials Information System 2015 (WHMIS 2015)
+ 3
German Federal Environment Agency – Substances Hazardous to Water
The Endocrine Disruption Exchange – Potential Endocrine Disruptors List
SAS Classification Model: ToxTree
|
|
U
No structural information available
|
1304-85-4
|
U
SAS Classification Model: ToxTree
Japan GHS
+ 2
New Zealand GHS
Canadian Domestic Substances List
|
|
U
No structural information available
|
-
|
U
EU GHS
|
|
U
No structural information available
|
72480-43-4
|
U
No Data Source
|
|
U
No structural information available
|
72480-45-6
|
U
No Data Source
|